Skip to main content
. 2018 Jul 1;10(1):e2018045. doi: 10.4084/MJHID.2018.045

Table 1.

Pretreatment laboratory characteristics of the patients

Complete blood counts Median Range

Hemoglobin, g/dL 8.7 4.7–13.4
WBC, ×103/μL 4 1–23.1
High-risk+ n= (%) 4 (23.5)
Low-intermediate-risk+ n= (%) 13 (76.5)
Platelet, ×103 21 4–209
LCirculating blasts*, % 38 0–100%

Fibrinogen level, g/L 149.5 73–505
+

Patients with Sanz high risk (WBC >/= 10 ×103/μ) versus low-intermediate risk (WBC <10 ×103/μL).

*

Data missing for 4 patients.